Myriad Genetics Announces Second Quarter Fiscal 2008 Financial Results Conference Call

* Reuters is not responsible for the content in this press release.

Tue Jan 22, 2008 12:33pm EST 

  SALT LAKE CITY, UT, Jan 22 (MARKET WIRE) -- 
 Myriad Genetics, Inc. (NASDAQ: MYGN) has arranged a conference call with the
management team to provide a company update. Peter D. Meldrum, President
and Chief Executive Officer, will host the call along with Jim Evans, Chief
Financial Officer; Gregory C. Critchfield, M.D., President of Myriad Genetic
Laboratories, Inc.; and Adrian N. Hobden, Ph.D., President of Myriad
Pharmaceuticals, Inc.


DATE: February 5, 2008
TIME: 10:00 am ET
DOMESTIC DIAL-IN: (888) 589-2820
INTERNATIONAL DIAL-IN: (706) 634-2173
CONFERENCE ID#  32258334
(Please dial in approximately 10 minutes before the call is scheduled
to begin)

    
A press release will be issued at 6:30 am ET.

    Replay of the call will be available from two hours after the call for seven
days by dialing (800) 642-1687 or (706) 645-9291, and entering the conference
ID number.

    A live audio Webcast will be available at: www.myriad.com

    

Contact:
Suzanne Barton
Myriad Genetics
(801) 584-1138

Copyright 2008, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.